Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Muramyl peptide-binding sites are located inside target cells.

M V Sumaroka1, I S Litvinov, S V Khaidukov

  • 1Shemyakin Institute of Bioorganic Chemistry, USSR Academy of Sciences, Moscow.

FEBS Letters
|December 16, 1991
PubMed
Summary

Specific muramyl peptide-binding sites are located within immune cells like T-lymphocytes and macrophages, and neuroblastoma cells. Intact glycopeptide molecules and specific configurations are crucial for binding.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Influence of Sodium and Silver Salts of Pyrazolecarboxamides on Innate Immunity Reactions In Vivo.

Bulletin of experimental biology and medicine·2026
Same author

[The effectiveness of using a centrally acting muscle relaxant in combination with botulinum toxin injections in patients with spasmodic torticollis].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2025
Same author

[Comparative analysis of the effectiveness of Botulinum toxin type A - hemagglutinin preparations of the Relatox and Botox complex in the treatment of patients with primary idiopathic blepharospasm].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2025
Same author

[BCG, muramylpeptides, trained immunity (part I): linkages in the light of the COVID-19 pandemic].

Terapevticheskii arkhiv·2021
Same author

[BCG, muramylpeptides, trained immunity (part II): a low molecular weight alternative to multicomponent bacterial immunostimulants for prevention of respiratory infections during a pandemic].

Terapevticheskii arkhiv·2021
Same author

Lipophilic Prodrug of Methotrexate in the Membrane of Liposomes Promotes Their Uptake by Human Blood Phagocytes.

Acta naturae·2020

Area of Science:

  • Immunology
  • Cell Biology
  • Biochemistry

Background:

  • Muramyl peptides are components of bacterial cell walls.
  • These peptides can interact with host cells, influencing immune responses.
  • Understanding these interactions requires identifying specific binding sites.

Purpose of the Study:

  • To investigate the cellular localization of muramyl peptide-binding sites.
  • To characterize the binding properties and affinity of these sites.
  • To determine the molecular requirements for effective muramyl peptide binding.

Main Methods:

  • Flow cytometry was used to analyze cell populations.
  • Fluorescence polarization assays were employed to quantify binding.
  • Inhibition analysis was performed to assess molecular requirements.

Related Experiment Videos

Main Results:

  • Muramyl peptide-binding sites were found intracellularly in T-lymphocytes, macrophages, and neuroblastoma cells.
  • No binding sites were detected on the cell surface or in B-cells.
  • WEHI-3 cells exhibited two binding sites with dissociation constants (Kd) of 21 nM and 540 nM.
  • Effective binding required an intact glycopeptide molecule and the D-configuration of the isoglutamine residue.

Conclusions:

  • Specific muramyl peptide-binding sites are located intracellularly in certain immune and cancer cells.
  • The binding affinity and specificity are dependent on the structural integrity and stereochemistry of the muramyl peptide.
  • These findings contribute to understanding the cellular interactions of bacterial components.